Por: RTTNews Health May 08, 2023
BioNTech SE () said its financial performance has been fully in line with the company's expectations for the first quarter of 2023. Commercial revenues decreased due to lower demand for COVID-19 vaccine. For fiscal 2023, the company continues to project BioNTech COVID-19 vaccine revenues of approximately 5 billion euros. In 2023, the company plans to deliver doses originally scheduled for delivery in 2022 in some geographies. BioNTech SE... + full article
CNBC USA Health March 27, 2023
Vials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022.Rodrigo Garrido ReutersShares of on Monday slid by more than 6% in morning trading after the... + más
FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5 | RTTNews
RTTNews USA Health March 15, 2023
The U.S. Food and Drug Administration has authorized bivalent Pfizer-BioNTech covid-19 vaccine as booster dose for certain children 6 months through 4 years of age.In a statement, the regulator said it has amended the emergency use authorization or EUA of the Pfizer-BioNTech... + más
Amid pathetic uptake, FDA green lights confusing COVID vaccine update for kids | Ars Technica
Politico USA Health February 09, 2023
The Centers for Disease Control and Prevention added Covid-19 vaccinations for children, adolescents and adults to its immunization schedule. These updates reflect current agency recommendations. Adding them formalizes that guidance for health care providers and schools. The... + más
States, not CDC, set school vaccination requirements | Los Angeles Times
FACT FOCUS: States, not CDC, set school vaccine requirements | ABC News
RTTNews USA Health December 06, 2022
Vaccine partners Pfizer Inc. and BioNTech SE are seeking emergency use authorization or EUA from the U.S. Food and Drug Administration to offer their bivalent COVID-19 vaccine to children 6 months through 4 years of age. If authorized, the vaccine would be part of a primary... + más
FDA greenlights bivalent vaccines for children as young as 6 months old | Politico
ABC News USA World October 18, 2022
LONDON -- The world could be only a few years away from a cancer vaccine, according to the couple behind the Pfizer/BioNtech COVID-19 vaccine.We feel that a cure for cancer or to changing cancer patients' lives is in our grasp, professor Ozlem Tureci told in an interview... + más
Cancer vaccine may be ready by 2030, say founders of COVID vaccine-makers BioNTech | ABC7
In Boston visit, BioNTech’s leaders say the pandemic isn’t close to being over | The Boston Globe
The Boston Globe USA Business October 08, 2022
Pfizer and BioNTech, the duo behind the world’s most widely used COVID-19 vaccine, and one of the most successful pharmaceutical products of all time, are developing a trio of new vaccines that could spur stronger, broader, and longer-lasting immunity to the... + más
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
About iurex | Privacy Policy | Disclaimer |